DE602005018103D1 - Materialien und verfahren zur minimal invasiven abgabe einer zellhaltigen fliessfähigen zusammensetzung - Google Patents
Materialien und verfahren zur minimal invasiven abgabe einer zellhaltigen fliessfähigen zusammensetzungInfo
- Publication number
- DE602005018103D1 DE602005018103D1 DE602005018103T DE602005018103T DE602005018103D1 DE 602005018103 D1 DE602005018103 D1 DE 602005018103D1 DE 602005018103 T DE602005018103 T DE 602005018103T DE 602005018103 T DE602005018103 T DE 602005018103T DE 602005018103 D1 DE602005018103 D1 DE 602005018103D1
- Authority
- DE
- Germany
- Prior art keywords
- implantable material
- cells
- methods
- materials
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
- A61L27/3808—Endothelial cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00005—The prosthesis being constructed from a particular material
- A61F2310/00365—Proteins; Polypeptides; Degradation products thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Botany (AREA)
- Vascular Medicine (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- External Artificial Organs (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US63415504P | 2004-12-08 | 2004-12-08 | |
US66385905P | 2005-03-21 | 2005-03-21 | |
US68205405P | 2005-05-18 | 2005-05-18 | |
PCT/US2005/043844 WO2006062871A2 (en) | 2004-12-08 | 2005-12-06 | Materials and methods for minimally-invasive administration of a cell-containing flowable composition |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602005018103D1 true DE602005018103D1 (de) | 2010-01-14 |
Family
ID=36578486
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602005022481T Active DE602005022481D1 (de) | 2004-12-08 | 2005-12-06 | Zusammensetzungen und deren verwendung für besseren gefässzugang |
DE602005018103T Active DE602005018103D1 (de) | 2004-12-08 | 2005-12-06 | Materialien und verfahren zur minimal invasiven abgabe einer zellhaltigen fliessfähigen zusammensetzung |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602005022481T Active DE602005022481D1 (de) | 2004-12-08 | 2005-12-06 | Zusammensetzungen und deren verwendung für besseren gefässzugang |
Country Status (12)
Country | Link |
---|---|
US (8) | US20080125858A1 (de) |
EP (5) | EP1824526B1 (de) |
JP (8) | JP2008522735A (de) |
CN (4) | CN103055350B (de) |
AT (2) | ATE450276T1 (de) |
AU (4) | AU2005314263B2 (de) |
CA (4) | CA2881343A1 (de) |
DE (2) | DE602005022481D1 (de) |
ES (2) | ES2490610T3 (de) |
HK (2) | HK1112428A1 (de) |
IL (5) | IL183785A (de) |
WO (1) | WO2006062962A2 (de) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9969980B2 (en) * | 2001-09-21 | 2018-05-15 | Garnet Biotherapeutics | Cell populations which co-express CD49c and CD90 |
US9969977B2 (en) * | 2002-09-20 | 2018-05-15 | Garnet Biotherapeutics | Cell populations which co-express CD49c and CD90 |
ES2347078T3 (es) | 2005-04-21 | 2010-10-25 | Massachusetts Institute Of Technology | Materiales y metodos para alterar una respuesta inmunologica a inmunogenos exogenos y endogenos, incluyendo celulas, tejidos u organos singeneicos y no singeneicos. |
WO2007001744A2 (en) | 2005-06-21 | 2007-01-04 | Pervasis Therapeutics, Inc. | Methods and compositions for enhancing vascular access |
US8529452B2 (en) * | 2006-06-02 | 2013-09-10 | Sandra Donnelly | Ultrasonic evaluation of venous structures |
EP2079478A2 (de) * | 2006-11-07 | 2009-07-22 | Pervasis Therapeutics, Inc. | Materialien und verfahren für behandlung und management von angiogenesevermittelten erkrankungen |
WO2008057590A2 (en) * | 2006-11-07 | 2008-05-15 | Pervasis Therapeutics, Inc. | Methods and compositions for modulating tissue modeling |
US20100239671A1 (en) | 2007-11-06 | 2010-09-23 | Edelman Elazer R | Tissue-Engineered Endothelial and Epithelial Implants Differentially and Synergistically Regulate Tissue Repair |
US8409228B2 (en) | 2008-06-06 | 2013-04-02 | Duane D. Blatter | Tissue management methods, apparatus, and systems |
US9179901B2 (en) | 2009-01-29 | 2015-11-10 | Vital Access Corporation | Vascular access ports and related methods |
US11197952B2 (en) | 2009-01-29 | 2021-12-14 | Advent Access Pte. Ltd. | Vascular access ports and related methods |
US8337465B2 (en) | 2009-01-29 | 2012-12-25 | Vital Access Corporation | Subcutaneous vascular access ports and related systems, methods, and implantation features |
EP2528537A4 (de) * | 2010-01-27 | 2016-09-07 | Vascular Therapies Inc | Vorrichtung und verfahren zur stenose-verhinderung an einer anastomose-stelle |
US8551130B2 (en) | 2010-02-18 | 2013-10-08 | Cardiovascular Systems, Inc. | Therapeutic agent delivery system, device and method for localized application of therapeutic substances to a biological conduit |
US9050414B2 (en) | 2010-02-19 | 2015-06-09 | Cardiovascular Systems, Inc. | Systems and methods for mixing therapeutic agents before and/or during administration |
US20110277778A1 (en) * | 2010-05-14 | 2011-11-17 | Tyco Healthcare Group Lp | System and Method for Diverticulitis Treatment |
JP2013528175A (ja) * | 2010-05-28 | 2013-07-08 | ガーネット バイオセラピューティクス インコーポレイテッド | インビトロで培養し、増殖させた自己複製コロニー形成細胞由来の成分を有する、生存しているおよび生存していない生理活性デバイスの組成物ならびにそれらの使用法 |
EP2739327B1 (de) * | 2011-08-01 | 2019-07-24 | Laminate Medical Technologies Ltd | Gefässformungsvorrichtungen |
US9433722B2 (en) * | 2011-08-09 | 2016-09-06 | Abbott Cardiovascular Systems Inc. | Vascular shield and delivery system |
AU2012296563B2 (en) * | 2011-08-17 | 2017-05-04 | Artio Medical, Inc. | System and method to increase the overall diameter of veins and arteries |
WO2014017986A1 (en) * | 2012-07-26 | 2014-01-30 | Agency For Science, Technology And Research | Vascular access device and guiding portion |
CN104837514B (zh) | 2012-08-01 | 2017-05-17 | 拉米内特医疗技术有限公司 | 用于使动静脉瘘成形的装置 |
US20150370707A1 (en) * | 2014-06-24 | 2015-12-24 | Qualcomm Incorporated | Disunited shared-information and private-information caches |
US20160029996A1 (en) * | 2014-08-01 | 2016-02-04 | Eric Johnson | Device and method for using ivus data to characterize and evaluate a vascular graft condition |
CN108271770B (zh) * | 2017-01-06 | 2021-06-22 | 中国科学院化学研究所 | 微米颗粒在低温冻存中的应用 |
US11147582B2 (en) | 2018-06-14 | 2021-10-19 | Cardio Flow, Inc. | Atherectomy devices and methods |
EP3809983A4 (de) * | 2018-06-22 | 2021-09-01 | Mayo Foundation for Medical Education and Research | Verfahren und materialien zur verbesserung der reifung von arteriovenösen fisteln und zur aufrechterhaltung der funktionalität von arteriovenösen fisteln |
EP3933032A4 (de) * | 2019-01-31 | 2022-11-23 | Beijing Cytoniche Biotechnology Co., Ltd. | Verfahren zur dreidimensionalen züchtung zur massenproduktion von stammzellen |
US20220305248A1 (en) * | 2019-06-18 | 2022-09-29 | Emodial S.R.L. | Implantable vascular access device |
IT201900009318A1 (it) * | 2019-06-18 | 2020-12-18 | Gianni Pecorari | Dispositivo di accesso vascolare per emodialisi permanentemente impiantabile in un paziente avente una fistola arterovenosa ed una confezione sterile contenente un dispositivo monouso di prelievo e/o d’immissione di sangue detta fistola arterovenosa |
IT202000013321A1 (it) | 2020-06-05 | 2021-12-05 | Gianni Pecorari | Dispositivo di accesso vascolare per emodialisi permanentemente impiantabile in un paziente, dispositivo di cicatrizzazione di accesso vascolare e confezione sterile contenente un dispositivo monouso di prelievo e/o di immissione di sangue utilizzabile in emodialisi |
CN115052644A (zh) * | 2020-02-14 | 2022-09-13 | 萩原明郎 | 血管吻合部的保护套 |
JPWO2021177273A1 (de) * | 2020-03-03 | 2021-09-10 | ||
JPWO2023037859A1 (de) * | 2021-09-08 | 2023-03-16 | ||
JPWO2023037861A1 (de) * | 2021-09-08 | 2023-03-16 | ||
US11931501B2 (en) | 2022-07-07 | 2024-03-19 | Evan T. Neville | Dialysis sheath for use in accessing a dialysis arteriovenous graft or fistula and methods of use |
US12004771B1 (en) | 2023-06-27 | 2024-06-11 | Cardio Flow, Inc. | Rotational atherectomy devices and methods |
Family Cites Families (78)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4418691A (en) * | 1981-10-26 | 1983-12-06 | Massachusetts Institute Of Technology | Method of promoting the regeneration of tissue at a wound |
US4787900A (en) * | 1982-04-19 | 1988-11-29 | Massachusetts Institute Of Technology | Process for forming multilayer bioreplaceable blood vessel prosthesis |
IL78950A (en) * | 1985-06-06 | 1991-12-15 | Univ Jefferson | Coating for prosthetic devices |
US4820626A (en) * | 1985-06-06 | 1989-04-11 | Thomas Jefferson University | Method of treating a synthetic or naturally occuring surface with microvascular endothelial cells, and the treated surface itself |
US4732155A (en) * | 1985-08-27 | 1988-03-22 | The Children's Medical Center Corporation | Implantable chemoattractant system |
US4675002A (en) * | 1985-12-02 | 1987-06-23 | Viles Joseph M | Liver assist device employing transformed cell lines |
US5863531A (en) * | 1986-04-18 | 1999-01-26 | Advanced Tissue Sciences, Inc. | In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework |
CA1340581C (en) * | 1986-11-20 | 1999-06-08 | Joseph P. Vacanti | Chimeric neomorphogenesis of organs by controlled cellular implantation using artificial matrices |
US6309635B1 (en) * | 1986-11-20 | 2001-10-30 | Children's Medical Center Corp. | Seeding parenchymal cells into compression resistant porous scaffold after vascularizing in vivo |
US5759830A (en) * | 1986-11-20 | 1998-06-02 | Massachusetts Institute Of Technology | Three-dimensional fibrous scaffold containing attached cells for producing vascularized tissue in vivo |
US5567612A (en) * | 1986-11-20 | 1996-10-22 | Massachusetts Institute Of Technology | Genitourinary cell-matrix structure for implantation into a human and a method of making |
US5736372A (en) * | 1986-11-20 | 1998-04-07 | Massachusetts Institute Of Technology | Biodegradable synthetic polymeric fibrous matrix containing chondrocyte for in vivo production of a cartilaginous structure |
US5202120A (en) * | 1987-09-11 | 1993-04-13 | Case Western Reserve University | Methods of reducing glial scar formation and promoting axon and blood vessel growth and/or regeneration through the use of activated immature astrocytes |
US5843156A (en) * | 1988-08-24 | 1998-12-01 | Endoluminal Therapeutics, Inc. | Local polymeric gel cellular therapy |
US5575815A (en) * | 1988-08-24 | 1996-11-19 | Endoluminal Therapeutics, Inc. | Local polymeric gel therapy |
CH676195A5 (de) * | 1988-10-07 | 1990-12-28 | Sulzer Ag | |
AU6747790A (en) * | 1989-11-13 | 1991-06-13 | President And Fellows Of Harvard College | Extraluminal regulation of the growth and repair of tubular structures in vivo |
US5527532A (en) * | 1989-11-13 | 1996-06-18 | President And Fellows Of Harvard College | Extraluminal regulation of the growth and repair of tubular structures in vivo |
US5540928A (en) * | 1991-02-27 | 1996-07-30 | President And Fellows Of Harvard College | Extraluminal regulation of the growth and repair of tubular structures in vivo |
US5246451A (en) * | 1991-04-30 | 1993-09-21 | Medtronic, Inc. | Vascular prosthesis and method |
CA2071137A1 (en) * | 1991-07-10 | 1993-01-11 | Clarence C. Lee | Composition and method for revitalizing scar tissue |
US5811447A (en) * | 1993-01-28 | 1998-09-22 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US5957972A (en) * | 1992-09-29 | 1999-09-28 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Implants possessing a surface of endothelial cells genetically-modified to inhibit intimal thickening |
US5399665A (en) * | 1992-11-05 | 1995-03-21 | Massachusetts Institute Of Technology | Biodegradable polymers for cell transplantation |
US6491938B2 (en) * | 1993-05-13 | 2002-12-10 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US5981568A (en) * | 1993-01-28 | 1999-11-09 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US5575686A (en) * | 1993-04-14 | 1996-11-19 | Burndy Corporation | Stacked printed circuit boards connected in series |
US5709854A (en) * | 1993-04-30 | 1998-01-20 | Massachusetts Institute Of Technology | Tissue formation by injecting a cell-polymeric solution that gels in vivo |
US5645829A (en) * | 1993-06-18 | 1997-07-08 | Beth Israel Hospital Association | Mesothelial cell gene therapy |
US6176874B1 (en) * | 1993-10-18 | 2001-01-23 | Masschusetts Institute Of Technology | Vascularized tissue regeneration matrices formed by solid free form fabrication techniques |
US5834029A (en) * | 1994-07-20 | 1998-11-10 | Cytotherapeutics, Inc. | Nerve guidance channel containing bioartificial three-dimensional hydrogel extracellular matrix derivatized with cell adhesive peptide fragment |
US6911216B1 (en) * | 1994-10-12 | 2005-06-28 | Genzyme Corporation | Targeted delivery via biodegradable polymers |
ES2155534T3 (es) * | 1994-10-12 | 2001-05-16 | Focal Inc | Administracion dirigida por medio de polimeros biodegradables. |
US5914268A (en) * | 1994-11-21 | 1999-06-22 | National Jewish Center For Immunology & Respiratory Medicine | Embryonic cell populations and methods to isolate such populations |
US6281015B1 (en) * | 1994-12-16 | 2001-08-28 | Children's Medical Center Corp. | Localized delivery of factors enhancing survival of transplanted cells |
US5716404A (en) * | 1994-12-16 | 1998-02-10 | Massachusetts Institute Of Technology | Breast tissue engineering |
US5591226A (en) * | 1995-01-23 | 1997-01-07 | Schneider (Usa) Inc. | Percutaneous stent-graft and method for delivery thereof |
US5855610A (en) * | 1995-05-19 | 1999-01-05 | Children's Medical Center Corporation | Engineering of strong, pliable tissues |
US5766584A (en) * | 1995-06-02 | 1998-06-16 | Massachusetts Institute Of Technology | Inhibition of vascular smooth muscle cell proliferation with implanted matrix containing vascular endothelial cells |
US6615071B1 (en) * | 1995-09-20 | 2003-09-02 | Board Of Regents, The University Of Texas System | Method and apparatus for detecting vulnerable atherosclerotic plaque |
US6480743B1 (en) * | 2000-04-05 | 2002-11-12 | Neuropace, Inc. | System and method for adaptive brain stimulation |
US6102884A (en) * | 1997-02-07 | 2000-08-15 | Squitieri; Rafael | Squitieri hemodialysis and vascular access systems |
US6886568B2 (en) * | 1998-04-08 | 2005-05-03 | The Johns Hopkins University | Method for fabricating cell-containing implants |
CA2351671A1 (en) * | 1998-11-24 | 2000-06-08 | Regents Of The University Of Minnesota | Transgenic circulating endothelial cells |
US6328762B1 (en) * | 1999-04-27 | 2001-12-11 | Sulzer Biologics, Inc. | Prosthetic grafts |
US6387116B1 (en) * | 1999-06-30 | 2002-05-14 | Pharmasonics, Inc. | Methods and kits for the inhibition of hyperplasia in vascular fistulas and grafts |
US6584590B1 (en) * | 1999-08-13 | 2003-06-24 | Lucent Technologies Inc. | JTAG port-sharing device |
US6555374B1 (en) * | 1999-08-19 | 2003-04-29 | Artecel Sciences, Inc. | Multiple mesodermal lineage differentiation potentials for adipose tissue-derived stromal cells and uses thereof |
ATE284674T1 (de) * | 1999-10-05 | 2005-01-15 | Transkaryotic Therapies Inc | Hybride matrizen und gemische davon |
US6461631B1 (en) * | 1999-11-16 | 2002-10-08 | Atrix Laboratories, Inc. | Biodegradable polymer composition |
US20010047843A1 (en) * | 1999-12-22 | 2001-12-06 | Reinig Maureen Louise | Handicraft process for creating cards |
WO2001062241A1 (en) * | 2000-02-23 | 2001-08-30 | Smithkline Beecham Corporation | Method for the prevention or reduction of vascular access dysfunction |
DE60130544T2 (de) * | 2000-03-13 | 2008-06-26 | Biocure, Inc. | Embolische zusammensetzungen |
KR100860860B1 (ko) * | 2000-03-15 | 2008-09-29 | 오르버스네이치 메디칼 인코포레이티드 | 내피 세포 부착을 촉진하는 코팅 |
US6506398B1 (en) * | 2000-04-28 | 2003-01-14 | Hosheng Tu | Device for treating diabetes and methods thereof |
EP1301197A2 (de) * | 2000-07-21 | 2003-04-16 | The Board Of Regents, The University Of Texas System | Apparat mit regulierter freisetzung von wachstums zur regeneration peripherer nerven |
WO2002028387A1 (en) * | 2000-10-03 | 2002-04-11 | Oncopharmaceutical, Inc. | Inhibitors of angiogenesis and tumor growth for local and systemic administration |
US6622031B1 (en) * | 2000-10-04 | 2003-09-16 | 3Com Corporation | Antenna flip-up on removal of stylus for handheld device |
JP3580239B2 (ja) * | 2000-10-19 | 2004-10-20 | 日本電気株式会社 | 言語選択同報システム及び言語選択同報方法 |
US6565601B2 (en) * | 2000-11-15 | 2003-05-20 | Micro Therapeutics, Inc. | Methods for vascular reconstruction of diseased arteries |
DE60131569T2 (de) * | 2000-11-28 | 2008-10-23 | The University Of Chicago, Chicago | Genetisch veränderter herpes virus für die behandlung von herz- und gefässerkrankungen |
DE60237671D1 (de) * | 2001-01-16 | 2010-10-28 | Vascular Therapies Llc | Implantierbare vorrichtung enthaltend resorbierbares matrixmaterial und antiproliferative wirkstoffe zur vorbeugung oder behandlung von versagen vaskulärer hämodialysezugänge und anderer vaskulärer transplantate |
US6723131B2 (en) * | 2001-02-28 | 2004-04-20 | The Cleveland Clinic Foundation | Composite bone marrow graft material with method and kit |
US6969373B2 (en) * | 2001-04-13 | 2005-11-29 | Tricardia, Llc | Syringe system |
WO2003015616A2 (en) * | 2001-08-17 | 2003-02-27 | Spencer Dudley W C | Hemodialysis assembly and method |
US6808518B2 (en) * | 2001-09-28 | 2004-10-26 | Ethicon, Inc. | Methods and devices for treating diseased blood vessels |
US20040047843A1 (en) * | 2002-02-12 | 2004-03-11 | Uab Research Foundation | Method for spinal cord reconnection |
US20050008629A1 (en) * | 2002-05-08 | 2005-01-13 | Interpore Orthopaedics, A Delaware Corporation | Encapsulated AGF cells |
US20060013852A1 (en) * | 2002-06-28 | 2006-01-19 | Prescott Margaret F | Use of organic compounds |
US20040156878A1 (en) * | 2003-02-11 | 2004-08-12 | Alireza Rezania | Implantable medical device seeded with mammalian cells and methods of treatment |
US20040215220A1 (en) * | 2003-04-24 | 2004-10-28 | Dolan Mark J. | Anastomotic stent, apparatus and methods of use thereof |
WO2005046516A2 (en) * | 2003-11-10 | 2005-05-26 | Angiotech International Ag | Medical implants and anti-scarring agents |
WO2005052138A1 (en) * | 2003-11-19 | 2005-06-09 | Wisconsin Alumni Research Foundation | Cryopreservation of pluripotent stem cells |
US20050208095A1 (en) * | 2003-11-20 | 2005-09-22 | Angiotech International Ag | Polymer compositions and methods for their use |
US20060004316A1 (en) * | 2004-07-02 | 2006-01-05 | Difiore Attilio E | Reduction of recirculation in catheters |
US7976517B2 (en) * | 2004-09-30 | 2011-07-12 | Codman & Shurtleff, Inc. | Fluid management flow implants of improved occlusion resistance |
WO2007053799A2 (en) * | 2005-10-19 | 2007-05-10 | Cd Solutions, Llc | Apparatus and method for mixing and transferring medications |
CA2628339C (en) * | 2005-11-07 | 2015-04-28 | Industrie Borla S.P.A. | Vented safe handling vial adapter |
-
2005
- 2005-12-06 US US11/792,335 patent/US20080125858A1/en not_active Abandoned
- 2005-12-06 EP EP05848586A patent/EP1824526B1/de not_active Not-in-force
- 2005-12-06 CN CN201210448869.3A patent/CN103055350B/zh not_active Expired - Fee Related
- 2005-12-06 ES ES09013159.0T patent/ES2490610T3/es active Active
- 2005-12-06 AT AT05848586T patent/ATE450276T1/de not_active IP Right Cessation
- 2005-12-06 EP EP05853004A patent/EP1824529B1/de not_active Not-in-force
- 2005-12-06 CN CN201010275893.2A patent/CN101940801B/zh not_active Expired - Fee Related
- 2005-12-06 JP JP2007545545A patent/JP2008522735A/ja active Pending
- 2005-12-06 EP EP09013159.0A patent/EP2184077B1/de not_active Not-in-force
- 2005-12-06 CN CN2010102329049A patent/CN101912637A/zh active Pending
- 2005-12-06 CA CA2881343A patent/CA2881343A1/en not_active Abandoned
- 2005-12-06 DE DE602005022481T patent/DE602005022481D1/de active Active
- 2005-12-06 AU AU2005314263A patent/AU2005314263B2/en not_active Ceased
- 2005-12-06 AT AT05853004T patent/ATE474608T1/de not_active IP Right Cessation
- 2005-12-06 CN CN2012102650132A patent/CN102772824A/zh active Pending
- 2005-12-06 EP EP10005481A patent/EP2226036A1/de not_active Withdrawn
- 2005-12-06 US US11/792,350 patent/US20080119946A1/en not_active Abandoned
- 2005-12-06 CA CA002589871A patent/CA2589871A1/en not_active Abandoned
- 2005-12-06 AU AU2005314312A patent/AU2005314312B2/en not_active Ceased
- 2005-12-06 DE DE602005018103T patent/DE602005018103D1/de active Active
- 2005-12-06 EP EP05853101A patent/EP1824417A2/de not_active Ceased
- 2005-12-06 WO PCT/US2005/044090 patent/WO2006062962A2/en active Application Filing
- 2005-12-06 AU AU2005314226A patent/AU2005314226B2/en not_active Ceased
- 2005-12-06 JP JP2007545539A patent/JP5674256B2/ja not_active Expired - Fee Related
- 2005-12-06 US US11/792,284 patent/US20080118561A1/en not_active Abandoned
- 2005-12-06 ES ES05848586T patent/ES2339798T3/es active Active
- 2005-12-06 CA CA2589588A patent/CA2589588C/en not_active Expired - Fee Related
- 2005-12-06 JP JP2007545559A patent/JP2008522738A/ja active Pending
- 2005-12-06 CA CA2589597A patent/CA2589597C/en not_active Expired - Fee Related
-
2007
- 2007-06-07 IL IL183785A patent/IL183785A/en not_active IP Right Cessation
- 2007-06-07 IL IL183784A patent/IL183784A/en not_active IP Right Cessation
- 2007-06-07 IL IL183786A patent/IL183786A/en not_active IP Right Cessation
-
2008
- 2008-02-21 HK HK08101924.1A patent/HK1112428A1/xx not_active IP Right Cessation
- 2008-02-21 HK HK08101925.0A patent/HK1112429A1/xx not_active IP Right Cessation
-
2010
- 2010-05-13 US US12/779,223 patent/US20100318016A1/en not_active Abandoned
- 2010-09-13 US US12/880,931 patent/US20110002973A1/en not_active Abandoned
- 2010-09-13 US US12/880,860 patent/US20110045054A1/en not_active Abandoned
- 2010-11-25 IL IL209574A patent/IL209574A/en not_active IP Right Cessation
- 2010-12-10 AU AU2010249280A patent/AU2010249280B2/en not_active Ceased
-
2011
- 2011-03-04 US US13/040,650 patent/US20110229549A1/en not_active Abandoned
- 2011-05-08 IL IL212764A patent/IL212764A0/en unknown
-
2012
- 2012-05-09 US US13/467,180 patent/US20130052166A1/en not_active Abandoned
- 2012-05-14 JP JP2012110766A patent/JP2012148164A/ja active Pending
- 2012-05-15 JP JP2012111453A patent/JP2012176260A/ja active Pending
- 2012-11-22 JP JP2012256574A patent/JP2013056202A/ja active Pending
- 2012-11-22 JP JP2012256581A patent/JP2013039431A/ja active Pending
-
2014
- 2014-11-27 JP JP2014239567A patent/JP2015042682A/ja not_active Withdrawn
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE602005018103D1 (de) | Materialien und verfahren zur minimal invasiven abgabe einer zellhaltigen fliessfähigen zusammensetzung | |
SG161258A1 (en) | Methods and compositions for enhancing vascular access | |
Yao et al. | Fibrin-based tissue-engineered blood vessels: differential effects of biomaterial and culture parameters on mechanical strength and vascular reactivity | |
CN102256609B (zh) | 衍生自前胃胞外基质的组织支架 | |
Cholewinski et al. | Tranexamic acid—an alternative to aprotinin in fibrin-based cardiovascular tissue engineering | |
CN104841017B (zh) | 一种具有抗凝血性能的去细胞化肝脏生物支架及其制备方法 | |
WO2007035843A3 (en) | Methods and compositions for organ and tissue functionality | |
JP2009525795A (ja) | 医療用接着剤および止血剤 | |
GB2434105A (en) | Fibronectin-modified ECM tissue graft constructs and methods for preparation and use thereof | |
Shtilʹman | Polymeric biomaterials | |
Kovacevic et al. | Cartilage scales embedded in fibrin gel | |
CN113117157A (zh) | 表面生物功能化的医用骨螺钉及其制备方法及其应用 | |
ATE411057T1 (de) | Injizierbare implantate auf keramikbasis zur füllung von weichgewebe | |
WO2006062909A3 (en) | Methods and compositions for enhancing vascular access | |
ATE349232T1 (de) | Biokompatibles poröses ti-ni material | |
CN105169494B (zh) | 一种组织工程皮肤的制备方法 | |
EP3060060B1 (de) | Gewebegezüchtete vorrichtungen und verfahren zur herstellung davon | |
Cai et al. | Development potential of extracellular matrix hydrogels as hemostatic materials | |
CN102100586A (zh) | 一种新型混合人工血管的制备方法 | |
CN208447853U (zh) | 一种隆鼻手术用的鼻假体 | |
BR112023018291A2 (pt) | Implante de reconstrução mamária | |
CN204133899U (zh) | 一种仿生复合补片 | |
Velnar et al. | Is tissue augmentation a reality in biosurgery? An experimental study of endothelial cell invasion into tissue filler | |
Nakabayashi | Preparation of new biomedical materials and their application in clinics | |
Furukawa et al. | Novel tissue-engineered artificial vascular graft model composed from cell, gel, and biodegradable scaffold |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |